Publikationen, an denen er mitarbeitet KEPA BELLOSO URIBE (9)

2022

  1. Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple-Cell 2D Atherosclerosis Model

    Small, Vol. 18, Núm. 13

2020

  1. Cholesterol efflux efficiency of reconstituted HDL is affected by nanoparticle lipid composition

    Biomedicines, Vol. 8, Núm. 10

  2. MiR-27b modulates insulin signaling in hepatocytes by regulating insulin receptor expression

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-16

2017

  1. Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene

    Atherosclerosis, Vol. 263, pp. 163-170

  2. Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Adenylate Cyclase Toxin promotes bacterial internalisation into non phagocytic cells

    Scientific Reports, Vol. 5

2013

  1. Ca2+ Influx and Tyrosine Kinases Trigger Bordetella Adenylate Cyclase Toxin (ACT) Endocytosis. Cell Physiology and Expression of the CD11b/CD18 Integrin Major Determinants of the Entry Route

    PLoS ONE, Vol. 8, Núm. 9

  2. Calpain-Mediated Processing of Adenylate Cyclase Toxin Generates a Cytosolic Soluble Catalytically Active N-Terminal Domain

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. Functional characterization of splicing and ligand-binding domain variants in the LDL receptor

    Human Mutation, Vol. 33, Núm. 1, pp. 232-243